Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study to Determine Bioequivalence Between Two Oral Tamsulosin Products as 0.4 mg Prolonged-release Tablets in Healthy Male Subjects Under Fasted Conditions

NCT07698275 is registered in ClinicalTrials.gov with ADIUM as lead sponsor.

NCT NCT07698275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07698275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study to Determine Bioequivalence Between Two Oral Tamsulosin Products as 0.4 mg Prolonged-release Tablets in Healthy Male Subjects Under Fasted Conditions
Lead sponsor
ADIUM
Phase
Not applicable
Overall status
Completed
Start date
January 12, 2026
Completion date
March 19, 2026
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bioequivalance